PLoS ONE (Jan 2019)

Random plasma glucose predicts the diagnosis of diabetes.

  • Mary K Rhee,
  • Yuk-Lam Ho,
  • Sridharan Raghavan,
  • Jason L Vassy,
  • Kelly Cho,
  • David Gagnon,
  • Lisa R Staimez,
  • Christopher N Ford,
  • Peter W F Wilson,
  • Lawrence S Phillips

DOI
https://doi.org/10.1371/journal.pone.0219964
Journal volume & issue
Vol. 14, no. 7
p. e0219964

Abstract

Read online

Aims/hypothesisEarly recognition of those at high risk for diabetes as well as diabetes itself can permit preventive management, but many Americans with diabetes are undiagnosed. We sought to determine whether routinely available outpatient random plasma glucose (RPG) would be useful to facilitate the diagnosis of diabetes.MethodsRetrospective cohort study of 942,446 U.S. Veterans without diagnosed diabetes, ≥3 RPG in a baseline year, and ≥1 primary care visit/year during 5-year follow-up. The primary outcome was incident diabetes (defined by diagnostic codes and outpatient prescription of a diabetes drug).ResultsOver 5 years, 94,599 were diagnosed with diabetes [DIAB] while 847,847 were not [NONDIAB]. Baseline demographics of DIAB and NONDIAB were clinically similar, except DIAB had higher BMI (32 vs. 28 kg/m2) and RPG (150 vs. 107 mg/dl), and were more likely to have Black race (18% vs. 15%), all pConclusionsRPG levels below the diabetes "diagnostic" range (≥200 mg/dl) provide good discrimination for follow-up diagnosis. Use of such levels-obtained opportunistically, during outpatient visits-could signal the need for further testing, allow preventive intervention in high risk individuals before onset of disease, and lead to earlier identification of diabetes.